Benzamides and related inhibitors of factor Xa
Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
1. A method for preventing or treating venous thrombosis in a mammal in need thereof, the method comprising administering to the mammal a therapeutically effective amount of a compound of formula
or a pharmaceutically acceptable salt thereof, and aspirin.
2. The method of claim 1 , wherein the salt is the maleate salt.
3. The method of claim 1 , wherein the compound is administered to the mammal in the form of a pharmaceutical composition comprising the compound, or a pharmaceutically accepted salt thereof, and a pharmaceutically acceptable carrier.
4. The method of claim 3 , wherein the pharmaceutical composition is in capsule form.
5. A method for preventing or treating deep venous thrombosis in a mammal in need thereof, the method comprising administering to the mammal a therapeutically effective amount of a compound of formula
or a pharmaceutically acceptable salt thereof, and aspirin.
6. The method of claim 5 , wherein the salt is the maleate salt.
7. The method of claim 5 , wherein the compound is administered to the mammal in the form of a pharmaceutical composition comprising the compound, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
8. The method of claim 7 , wherein the pharmaceutical composition is in capsule form.
9. A method for preventing or treating pulmonary embolism in a mammal in need thereof, the method comprising administering to the mammal a therapeutically effective amount of a compound of formula
or a pharmaceutically acceptable salt thereof, and aspirin.
10. The method of claim 9 , wherein the salt is the maleate salt.
11. The method of claim 9 , wherein the compound is administered to the mammal in the form of a pharmaceutical composition comprising the compound, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
12. The method of claim 11 , wherein the pharmaceutical composition is in capsule form.